CSL Behring has dedicated decades to the Bleeding Disorders Community. With a history spanning over 100 years, CSL Behring has been focused on serving patients’ needs by using the latest technologies to develop and deliver innovative therapies. Our advances in hemophilia treatment, and serving that community, have spanned decades.
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. We meet patients’ needs using the latest technologies to develop and deliver innovative therapies. The company offers a broad range of products in the industry for treating coagulation disorders, primary immune deficiencies, hereditary angioedema, respiratory disease, and chronic inflammatory demyelinating polyneuropathy (CIDP).